Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule

BACKGROUND: In the Netherlands, the bivalent human papillomavirus (HPV) vaccine has been offered to preadolescent girls via the National Immunization Program in a 2-dose schedule since 2014. The current study estimates vaccine effectiveness (VE) against HPV infections up to 4 years postvaccination a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoes, Joske, King, Audrey J, Klooster, Tessa M Schurink van’t, Berkhof, Johannes, Bogaards, Johannes A, de Melker, Hester E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441205/
https://www.ncbi.nlm.nih.gov/pubmed/33964158
http://dx.doi.org/10.1093/infdis/jiab250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441205/
https://www.ncbi.nlm.nih.gov/pubmed/33964158
http://dx.doi.org/10.1093/infdis/jiab250

Ejemplares similares